sschmid	10.1158/1535-7163.TARG-09-C220	<http://dx.doi.org/10.1158/1535-7163.targ-09-c220>; rel="canonical", <https://syndication.highwire.org/content/doi/10.1158/1535-7163.TARG-09-C220>; version="vor"; rel="item"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.1158/1535-7163.TARG-09-C220"><j.1:endingPage>C220</j.1:endingPage><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/r-krumbholz-1vmuyvk26um7b"><j.3:name>R. Krumbholz</j.3:name><j.3:familyName>Krumbholz</j.3:familyName><j.3:givenName>R.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/s-dunham-1vmuyvk26um7b"><j.3:name>S. Dunham</j.3:name><j.3:familyName>Dunham</j.3:familyName><j.3:givenName>S.</j.3:givenName></j.3:Person></j.0:creator><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#date" >2009-12-10</j.0:date><owl:sameAs rdf:resource="info:doi/10.1158/1535-7163.targ-09-c220"/><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/1535-7163"><j.1:issn>1538-8514</j.1:issn><j.2:issn>1538-8514</j.2:issn><owl:sameAs>urn:issn:1538-8514</owl:sameAs><owl:sameAs>urn:issn:1535-7163</owl:sameAs><j.0:title>Molecular Cancer Therapeutics</j.0:title><j.1:issn>1535-7163</j.1:issn><j.2:issn>1535-7163</j.2:issn></j.2:Journal></j.0:isPartOf><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/s-roth-1vmuyvk26um7b"><j.3:name>S. Roth</j.3:name><j.3:familyName>Roth</j.3:familyName><j.3:givenName>S.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/s-m-schmid-1vmuyvk26um7b"><j.3:name>S. M. Schmid</j.3:name><j.3:familyName>Schmid</j.3:familyName><j.3:givenName>S. M.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/c-bormann-1vmuyvk26um7b"><j.3:name>C. Bormann</j.3:name><j.3:familyName>Bormann</j.3:familyName><j.3:givenName>C.</j.3:givenName></j.3:Person></j.0:creator><j.0:publisher>American Association for Cancer Research (AACR)</j.0:publisher><j.1:volume>8</j.1:volume><owl:sameAs rdf:resource="http://dx.doi.org/10.1158/1535-7163.targ-09-c220"/><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/e-lavoie-1vmuyvk26um7b"><j.3:name>E. LaVoie</j.3:name><j.3:familyName>LaVoie</j.3:familyName><j.3:givenName>E.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/t-oshea-1vmuyvk26um7b"><j.3:name>T. O'Shea</j.3:name><j.3:familyName>O'Shea</j.3:familyName><j.3:givenName>T.</j.3:givenName></j.3:Person></j.0:creator><j.0:identifier>10.1158/1535-7163.targ-09-c220</j.0:identifier><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/b-a-teicher-1vmuyvk26um7b"><j.3:name>B. A. Teicher</j.3:name><j.3:familyName>Teicher</j.3:familyName><j.3:givenName>B. A.</j.3:givenName></j.3:Person></j.0:creator><j.2:pageStart>C220</j.2:pageStart><j.2:doi>10.1158/1535-7163.targ-09-c220</j.2:doi><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/r-fang-1vmuyvk26um7b"><j.3:name>R. Fang</j.3:name><j.3:familyName>Fang</j.3:familyName><j.3:givenName>R.</j.3:givenName></j.3:Person></j.0:creator><j.2:pageEnd>C220</j.2:pageEnd><j.1:doi>10.1158/1535-7163.targ-09-c220</j.1:doi><j.1:startingPage>C220</j.1:startingPage><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/l-kurtzberg-1vmuyvk26um7b"><j.3:name>L. Kurtzberg</j.3:name><j.3:familyName>Kurtzberg</j.3:familyName><j.3:givenName>L.</j.3:givenName></j.3:Person></j.0:creator><j.2:volume>8</j.2:volume><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/j-crawford-1vmuyvk26um7b"><j.3:name>J. Crawford</j.3:name><j.3:familyName>Crawford</j.3:familyName><j.3:givenName>J.</j.3:givenName></j.3:Person></j.0:creator><j.0:title>Abstract C220: Genz-644282, a non-camptothecin topoisomerase one inhibitor, demonstrates a wide spectrum of in vitro and in vivo antitumor activity</j.0:title><owl:sameAs rdf:resource="doi:10.1158/1535-7163.targ-09-c220"/></rdf:Description></rdf:RDF>
